NCT03821467View on ClinicalTrials.gov

Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

December 12, 2025

Study Completion Date

December 12, 2025

Conditions
Ocular Blood Flow
Interventions
DEVICE

Dual beam Doppler Fourier-domain OCT (DOCT)

Retinal blood flow will be assessed using DOCT.

DEVICE

Dynamic Vessel Analyzer (DVA)

Retinal vessel diameters and oxygen saturation will be measured with the DVA device.

DEVICE

Optical coherence tomography (OCT)

Retinal morphology will be imaged using OCT.

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER